Of patients >50 years (n = 789), 26% (n = 209) showed at least one risk factor motivating a tumor bed boost according to current guidelines (negative HR-status, positive Her2neu-status, KI67 ≥30%, tumor size ≥2 cm, multifocality, pN1/× and EIC+). Here, MKI67 is linked to neoplasm.